Absci Corporation has grown revenue −43% a year over three years and −22% a year over five. Revenue growth, 3-year annual rate: −43% (Biotechnology median +21%). Revenue growth, 5-year rate: −22%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

ABSIAbsci Corporation

HealthcareUSD

$9.22

$2.3052 weeks$10.59

Is it growing?

Is ABSI growing?

Absci Corporation has grown revenue −43% a year over three years and −22% a year over five.

−43%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −22%
Revenue growth, 5-year rate · −43% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›